These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

281 related items for PubMed ID: 21736929

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Non-invasive iontophoretic delivery of enzymatically active ribonuclease A (13.6 kDa) across intact porcine and human skins.
    Dubey S, Kalia YN.
    J Control Release; 2010 Aug 03; 145(3):203-9. PubMed ID: 20423719
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. In vitro transdermal iontophoretic delivery of penbutolol sulfate.
    Ita KB, Banga AK.
    Drug Deliv; 2009 Jan 03; 16(1):11-4. PubMed ID: 19555303
    [Abstract] [Full Text] [Related]

  • 5. Microneedle assisted iontophoretic transdermal delivery of prochlorperazine edisylate.
    Kolli CS, Xiao J, Parsons DL, Babu RJ.
    Drug Dev Ind Pharm; 2012 May 03; 38(5):571-6. PubMed ID: 21980925
    [Abstract] [Full Text] [Related]

  • 6. In-vitro and in-vivo transdermal iontophoretic delivery of tramadol, a centrally acting analgesic.
    Takasuga S, Yamamoto R, Mafune S, Sutoh C, Kominami K, Yoshida Y, Ito M, Kinoshita M.
    J Pharm Pharmacol; 2011 Nov 03; 63(11):1437-45. PubMed ID: 21988424
    [Abstract] [Full Text] [Related]

  • 7. Combined effects of iontophoretic and chemical enhancement on drug delivery. II. Transport across human and murine skin.
    Nolan LM, Corish J, Corrigan OI, Fitzpatrick D.
    Int J Pharm; 2007 Aug 16; 341(1-2):114-24. PubMed ID: 17502130
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. In vitro and in vivo evaluation of the transdermal iontophoretic delivery of sumatriptan succinate.
    Patel SR, Zhong H, Sharma A, Kalia YN.
    Eur J Pharm Biopharm; 2007 May 16; 66(2):296-301. PubMed ID: 17182233
    [Abstract] [Full Text] [Related]

  • 12. In vitro and in vivo transdermal iontophoretic delivery of naloxone, an opioid antagonist.
    Yamamoto R, Takasuga S, Yoshida Y, Mafune S, Kominami K, Sutoh C, Kato Y, Yamauchi M, Ito M, Kanamura K, Kinoshita M.
    Int J Pharm; 2012 Jan 17; 422(1-2):132-8. PubMed ID: 22108639
    [Abstract] [Full Text] [Related]

  • 13. Effect of iontophoresis and penetration enhancers on transdermal absorption of metopimazine.
    Bounoure F, Lahiani Skiba M, Besnard M, Arnaud P, Mallet E, Skiba M.
    J Dermatol Sci; 2008 Dec 17; 52(3):170-7. PubMed ID: 18678472
    [Abstract] [Full Text] [Related]

  • 14. Effect of permeation enhancers on the iontophoretic transport of metoprolol tartrate and the drug retention in skin.
    Nair A, Vyas H, Shah J, Kumar A.
    Drug Deliv; 2011 Jan 17; 18(1):19-25. PubMed ID: 20726811
    [Abstract] [Full Text] [Related]

  • 15. Transdermal iontophoresis of the dopamine agonist 5-OH-DPAT in human skin in vitro.
    Nugroho AK, Li L, Dijkstra D, Wikström H, Danhof M, Bouwstra JA.
    J Control Release; 2005 Mar 21; 103(2):393-403. PubMed ID: 15763622
    [Abstract] [Full Text] [Related]

  • 16. Passive and iontophoretic permeation of glipizide.
    Jain A, Ghosh B, Rajgor N, Desai BG.
    Eur J Pharm Biopharm; 2008 Aug 21; 69(3):958-63. PubMed ID: 18291633
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effect of DC/mDC iontophoresis and terpenes on transdermal permeation of methotrexate: in vitro study.
    Prasad R, Koul V, Anand S, Khar RK.
    Int J Pharm; 2007 Mar 21; 333(1-2):70-8. PubMed ID: 17116378
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.